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Long-term follow-up of Brugada syndrome according to initial pre-
sentation and results of programmed ventricular stimulation
Béatrice Brembilla-Perrot, Gabriel Cismaru, Jean-Marc Sellal, Arnaud
Olivier, Jérôme Schwartz, Hugues Blangy, Luc Freysz, Claire Lalevee,
Nicolas Sadoul
CHU Brabois, Cardiologie, Vandoeuvre Les Nancy, 
The purpose of the study was to report the follow-up of Brugada syndrome
(BS) according to initial presentation and results of programmed ventricular
stimulation (PVS).
Methods: 64 patients, 57 males, 7 females aged from 21 to 74 years, mean
45±13, with a type 1 Brugada pattern were studied: 34 patients were asymp-
tomatic, but 17 had family history of unexplained sudden death (SD) before
40 years; 21 were studied for syncope, 5 were resuscitated from SD and 2 had
a monomorphic ventricular tachycardia (VT). All patients underwent echocar-
diography, exercise testing and Holter monitoring. PVS was performed in all
but 4 patients, 3 with resuscitated SD and one with VT. ICD was implanted
in 48 patients. Two asymptomatic patients without familial history of SD, but
with inducible VF were treated by hydroquinidine and PVS became negative.
Implantable loop recorder was used in remaining patients. Mean follow-up
was 6±4 years.
Results: At PVS, VF was induced in 29 patients, nonsustained (NS) VF
(29.4±11 sec) in 11 patients, VT in one patient. PVS remained negative in
remaining patients. During follow-up, 2 patients died from non cardiac death,
6 presented electrical shock-terminated VF, 1 a monomorphic VT and
4 NSVF. Remaining patients had no events. Results are detailed in the table.
The sensitivity of VF induction to predict later occurrence of a significant
event (VF, VT, NSVF) was 42% and specificity 55%. The sensitivity of VF
and NSVF induction was 50%, but specificity was 38%.
Conclusions: Despite a low sensitivity (42%), PVS remains a means to
evaluate the risk of subsequent major events in BS with a specificity of 55%
when VF was induced. Induction of NSVF could have also a clinical signifi-
cance and improved the sensitivity to 50%.
Table. Results
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Early repolarization syndrome in patients with myotonic dystrophy
disease: prevalence and prognostic implications
Zied Frikha (1), Olivier Huttin (2), Pierre Kaminsky (3), Beatrice
Brembilla-Perrot (2)
(1) Hôpitaux de tunis, Cardiologie, Sfax, Tunisie – (2) Lorrain Institute of
Heart and Vessels, Vandoeuvre les Nancy, France, Nancy, France – (3) Uni-
versity Hospital of Nancy – Hospital Brabois, Vandoeuvre les Nancy, France,
Nancy, France
Background: Heart involvement in myotonic dystrophy (MD) is charac-
terized by conduction system abnormalities, supraventricular and ventricular
arrhythmias and various ECG disorders like long QT syndrome and Brugada
syndrome. However, Early Repolarization Syndrome (ERS) was never
reported in patients with MD. So we aimed to determine whether ERS could
be previously overlooked in MD.
Methods: The electrocardiograms of 89 patients with genetically proven type
1 MD were independently reviewed by two cardiologists. ERS was considered
present if at least two adjacent precordial leads showed elevation of the ST seg-
ment ≥1mm. The amplitude, the morphology of ST elevation and the leads where
it was present were analysed together with QRS duration, QT and QTc duration.
Results: J-point elevation of at least 0.1 mV was identified in 7 of
89 patients with MD representing a prevalence of 9%. Among these patients,
the elevation was in the inferior leads in 5 cases (5.6%) and in the lateral leads
in 2 patients (2.2%). Only 2 patients (1.1%) had an elevation in both inferior
and lateral leads. J-point elevation of more than 0.2 mV occurred only in
2 patients (2.2%). Among the 7 patients with J-point elevation on the baseline
ECG who underwent a repeat electrocardiographic examination (an average of
5 years after baseline), the ERS pattern (≥0.1 mV) was again observed in all
of these patients (100%). The comparison between the baseline characteristics
of patients with and those without the ERS pattern showed some differences:
Patients with J-point elevation in inferior leads were more often men (p=0.03),
furthermore, they had a shorter QTc interval (p=0.04) and likely a shorter
QRS duration (p=0.06). During the mean follow-up of 5 years, we have
registered neither sudden death nor sudden arrhythmia in MD with ERS.
Conclusion: The high prevalence of ERS in our patients with MD suggests
a link between both diseases. The long-term outcome associated with ERS in
our population seems to have a benign character.
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Ajmaline test in SCN5A mutation carriers
Jean-Baptiste Gourraud (1), Floriane Simonet (2), Christian Dina (2), Fre-
deric Sacher (3), Philippe Mabo (4), Philippe Maury (5), Dominique
Babuty (6), Jean Marc Dupuis (7), Vincent Portero (8), Stephanie Chatel
(1), Jean Jacques Schott (2), Richard Redon (2), Hervé Le Marec (2), Vin-
cent Probst (1)
(1) CHU Nantes HGRL, L'Institut du Thorax, Nantes, France – (2) UMR
1087, IRT UN, L'institut du thorax, Nantes, France – (3) CHU Bordeaux,
Hôpital Cardiologique, Bordeaux, France – (4) CHU Rennes, Service de
Cardiologie, Rennes, France – (5) CHU Toulouse, Service de Cardiologie
Toulouse, France – (6)CHU Tours, Service de Cardiologie France –
(7) CHU d'Angers, Service de Cardiologie, Angers, France – (8) Unité
INSERM U915, IRT UN, L'institut du thorax, Nantes, France
Introduction: Inactivating mutations and frequent variants in the SCN5A
gene have been associated with Brugada syndrome. These mutations are
known to generate a myocardial transmural electrical gradient that could
explain the ‘Brugada’ ECG pattern. Thus, Na channel blocker drug can reveal
this pattern. However, the response to this test depending on the presence of
SCN5A mutation and frequent variant had never been described.
Methods: ECG parameters (P, PR, QRS, QT peak and QT end intervals ;
J wave amplitude in V1, V2, V3) were double measured in 73 unrelated Bru-
gada patients with a positive NA blocker challenge, as a blind test against
genetic status.
Results: The 10 patients carrying known SCN5A mutations (14%) didn’t
show any clinical differences at baseline with those without SCN5A mutation.
Baseline ECGs revealed a lengthening of PR (181±27 vs 156±30 ; p=0.017) and
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Events (follow-up) No VF VT NSVF
Number 53 6 1 5
Age 44±12 41±11 54 55±12
Female 6 0 0 1
Symptoms:VF 3 2 0 0
Symptoms:VT 1 1 0 0
Symptoms:syncope 16 1 1 3
Symptoms:no 33 0 0 1
PVS:not performed 2 2 0 0
PVS:negative 17 1 0 1
PVS:VF 24 2 1 2
PVS:NSVF 9 1 0 1
PVS:VT 1 0 0 0
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QRS interval (101±15 vs 89±14 ; p=0.02). No other parameter was significantly
different.
Once ECG parameters fulfilled diagnostic criteria for Brugada pattern,
ECG parameters were not significantly different in the 2 groups.
A similar effect on ECG was found in patients without SCN5A mutations
but carrying frequent variants associated with ECG. This effect was progres-
sive according to allele number.
According to the genetic status, no clinical difference was found after a
mean follow up of 6 years.
Conclusion: SCN5A mutations and frequent variant in Brugada patients lead
to a relative baseline lengthening of PR and QRS interval that disappears during
NA blocker test. It suggests a non cumulative and a saturable effect of SCN5A
that appears to be not essential in brugada syndrome’s pathophysiology.
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New mechanisms underlying the variable phenotypes caused by N-
and C-terminal SCN5A mutations
Azza Ziyadeh-Isleem (1), Jérôme Clatot (2), Sabine Duchatelet (1), Estelle
Gandjbakhch (1), Isabelle Denjoy (3), Françoise Hidden-Lucet (4), Isa-
belle Deschênes (5), Stéphane Hatem (1), Alain Coulombe (1), Nathalie
Neyroud (1), Pascale Guicheney (1)
(1) Inserm-UPMC UMR_S 956, Paris, France – (2) Inserm-UPMC
UMR_S 956 (Paris, France), Heart and Vascular Research Center, Case
Western Reserve University, Cleveland, Etats-Unis – (3) inserm U956,
Service de cardiologie, Paris, France – (4) Hôpital La Pitié-Salpêtrière,
Cardiologie, Paris, France – (5) Heart and Vascular Research Center,
Case Western Reserve University, Cleveland, Etats-Unis
Numerous SCN5A mutations affect the cardiac sodium channel Nav1.5 α-sub-
unit and cause several types of arrhythmias. By expressing N- and C-terminal
SCN5A mutations (R104W and R1860GfsX12) with wild-type (WT) channels in
HEK cells to mimic the heterozygous state of the patients, we showed that inter-
actions between α-subunits could modulate the channel function, location and
potentially the disease phenotypes.
When expressed alone, the N- and C-terminal mutants were mostly
degraded and showed either reduced or no INa density. When co-expressed
with WT channels, the N-terminal mutant exerted a dominant-negative effect
on WT channels by retaining them in the endoplasmic reticulum. In contrast,
co-transfection of WT channels with C-terminal mutants almost restored the
INa density to the level of WT and increased total and cell surface protein
expression of mutant channels, suggesting that WT allow mutant proteins to
escape proteasomal degradation. Co-immunoprecipitation studies showed that
the WT α-subunits interacted with each other, as well as with the N- and C-
terminal mutants. In addition, altered biophysical properties of INa current were
found at the heterozygous state for both mutants.
In conclusion, interaction between Nav1.5 α-subunits could explain the
variable phenotypes observed in SCN5A-mutation carriers. The N-terminal
variant associated with a loss-of-function due to its dominant-negative effect
on WT channels lead to a Brugada type-I ECG pattern. In contrast, the partial
rescue of the INa current of the C-terminal variant and its altered biophysical
properties could explain the complex clinical picture of sick sinus syndrome
and atrial fibrillation without Brugada ECG pattern.
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Early repolization variant frequently detected in young adults in Algeria
Walid Amara [Orateur] (1), Naima Hammoudi (2), Sid-Ali Bouallouche
(1), Aymen Elhraiech (1), Aylin Iusuf (1), Rachid Bougherbal (2)
(1) CH Le Raincy-Montfermeil, Service Cardiologie, Montfermeil, France –
(2) EHS Maouche, Service Cardiologie, Alger, Algérie
Background: Early repolarization variant (ERV) is considered to be a benign
condition, but recently its presence has been related with a certain vulnerability to
ventricular fibrillation in many case reports and case-control studies. The ERV
was the subject of many studies in highly developed countries and its prevalence
is estimated between 3.3 and 6.7%. ERV prevalence in the Maghrebian population
is unknown. The aim of this study was to appreciate the prevalence of the ERV
within a sample group of healthy Algerian young adults. 
Methods: ERV prevalence was assessed within a sample group of 441 healthy
male and female subjects (average age: 25 years old; age ranges: 18 to 36 years
old) using 12-lead electrocardiography. Three independent cardiologists interpreted
the ECGs and ERV was stratified according to the J-point elevation (≥0.1 mV) in
the inferior, apicolateral or both leads associated with QRS slurring or notching. 
Results: The ERV pattern was found in 55 subjects (12.4%). A malignant
ERV (>2mm) was discovered in 5 subjects (0.9%). Seventeen subjects (3.8%)
presented the ERV pattern in the lateral leads, 16 (3.6%) in the inferior leads,
and 22 (5%) in both lateral and inferior leads. Notch pattern was present in
14 subjects (3.2%), slur pattern in 30 subjects (6,8%), and a combination of
the two patterns in 11 subjects (2.5%). The ERV pattern was more prevalent
in males (15.6%) than in females (11.2%). The ERV prevalence was not
higher among the youngest subjects. None of the participants experienced
symptoms nor had a history of familial sudden death.
Conclusion: ERV is a common finding among a young healthy Algerian
population. Its prevalence seems to be more important than in highly devel-
oped countries. 
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Identification of rare RYR2 variants in arrhythmogenic right ventri-
cular cardiomyopathy/dysplasia: result of a systematic screening
Estelle Gandjbakhch (1), Nathalie Roux-Buisson (2), Véronique Fressart
(3), Erwan Donal (4), Vincent Probst (5), Philippe Chevalier (6), Didier
Klug (7), Françoise Hidden-Lucet (1), Julien Fauré (2), Philippe Charron (1)
(1) Hôpital La Pitié Salpétrière, Cardiologie, Paris, France – (2) CHU
Grenoble, La Tronche, France – (3) Hôpital La Pitié Salpétrière, Cardio-
gnétique et Myogénétique, Paris, France – (4) CHU Rennes-Hôpital Pon-
tchaillou, Cardiologie, Rennes, France – (5) CHU Nantes , Institut du
thorax, Service de Cardiologie, Nantes, France – (6) CHU Lyon, Cardio-
logie, Lyon, France – (7) CHU Lille, Cardiologie, Lille, France
Background: Arrhythmogenic right ventricular Cardiomyopathy/Dysplasia
(ARVC/D) is predominantly caused by desmosomal gene mutations that account
for only ~50% of cases. RYR2 gene mutations usually cause Catecholaminergic
Polymorphic Ventricular Tachycardia (CPVT) but have been associated with
peculiar phenotype named ARVC/D 2. We aim to determine the prevalence and
phenotype associated with RYR2 mutations in a large ARVC/D population. 
Methods and results: We have analyzed the whole RyR2 coding sequence
in a population of 64 ARVC/D probands without desmosomal gene mutations.
Six heterozygous putative missense mutations were identified in six unrelated
probands. Two (p.P1583S et p.L4670V) were considered as disease-causing
mutations and four (p.A2213S, p.G2367R, p.Y2932H, p.V3219M) were
considered as genetic variants of unknown significance (GVUS). Phenotypes
associated with RyR2 variants were unremarkable, associating typical ECG
abnormalities at rest, frequent monomorphic ventricular tachycardia, right
ventricular dilatation, wall motion abnormalities and fibro-fatty replacement
when histopathological examination was available. 
Conclusion: In this first systematic screening of the whole coding region
of the RYR2 gene in a large ARVC/D cohort without mutation in desmosomal
genes, we show that putative mutations (i) are not infrequent (9% of ARVC/
D probands), (ii) are associated with a conventional phenotype of ARVC/D,
not overlapping with CPVT, in contrast with previous findings and, (iii) are
all, except one, located in the cytoplasmic region of the protein, in contrast
with CPVT mutations. Therefore, we propose that RYR2 gene could be added
to the panel of genes analysed in patients with conventional ARVC/D.
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Telemonitoring in atrial fibrillation: feasibility study and results of
observational study on 130 patients
Patrick Dary 
Cabinet de Cardiologie, Saint Yrieix La Perche, France
Objectives: Atrial fibrillation (AF) increases the risk of stroke by 5. This
observational study in 130 patients assesses the diagnostic and therapeutic
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advantages of distance monitoring of the electrocardiogram (ECG) in an at-
risk population.
Protocol: Patients were enrolled either with symptoms of AF with the aim
of enhancing the sensitivity of detection or with confirmed AF to optimise
anti-arrhythmia (AA) and anticoagulant (AC) treatment.
Method: Patients were asked to self-monitor their heart rate (HR) by
wearing a Holter monitor for 10 hours/day outside the hospital. AF were
detected and the tracings automatically transmitted by telephone to a secure
server for analysis of HR and measurement of conduction times.
Results: 130 patients: 49% men and 51% women, mean age of 65 years
old.10% had already experienced a stroke. 28% presented with AF, 33% were
taking an AA and 25% AC.
For the 94 patients in sinus rhythm (72%): monitoring lasted 11 days,
240 ECG were transmitted (11 h/d). CHADSVasc=1.9. Changes were assessed as:
– absence of abnormality (43%)
– onset of AF (33%) and rise in number of patients taking AC from 35 to
58%, and AA from 32% to 71%
– discovery of regular tachycardia (24%) treated with HR control medications 
For the 36 patients (28%) who already had arrhythmia, telemonitoring was
an alternative to hospitalisation. Follow-up lasted 9 days, 276 ECG were
transmitted (10 h/d). CHADSVasc=2.4. Initiation of AC rose rapidly from
30% to 89%:
– HR controlled (59%), dropping from 100 to 77/min and monitoring for
medications increasing from 14% to 70%
–  return to sinus rhythm (41%) showing the effects of the AA taken from
22% to 81%
Conclusions: Telemonitoring allows diagnosis, monitor and treat AF.
Daily monitoring of the ECG allows rapid introduction of AC treatment and
enhances the safety of AA and HR control medications since the dosages pre-
scribed can be modified under real time conditions on the basis of heart rate
and rhythm measurements and conduction times.
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Percutaneous axillary vein access to implant implantable cardiac
defibrillators
Alexis Mechulan (1), Eric Peyrouse (2), Sébastien Prévôt (1), Philippe
Taghji (1), Jean-Claude Deharo (1)
(1) Hôpital la Timone, Cardiologie, Marseille, France – (2) Hôpital la
Timone, Cardiologie – Rythmologie, Marseille, France
Introduction: Subclavian vein access is a quick technique to implant ICD.
Pneumothorax is a well-known complication of this access. Cephalic vein
access avoids this complication, but this technique is more challenging and the
access through the cephalic vein could not be obtained in every patients. Per-
cutaneous axillary vein access is a quick technique with no risk of pneumo-
thorax but there are few data regarding ICD insertion using the axillary vein.
The aim of this study was to evaluate percutaneous axillary vein access as first
line strategy in patients undergoing ICD insertion. 
Methods: From April 2012 to April 2013, 19 patients who underwent ICD
insertion were prospectively included in the study. Nine patients had a single
chamber ICD and 10 patients had a dual chamber ICD implanted. The axillary
vein was percutaneously accessed using fluoroscopy. The landmark used was
the top of the first rib on the antero-posterior view (figure 1). No contrast was
used. 
Results: Fourteen patients (74%) had their ICD implanted through the axil-
lary vein. In five patients in whom the axillary vein could not be accessed or
found, the ICD was implanted through the subclavian vein. There was no
complication related to the axillary vein access. 
Conclusion: Using the axillary vein access as first line strategy to implant
ICD is safe and highly effective. Further studies have to be done to compare
this access to the subclavian and cephalic access.  
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Clinical implications of left ventricular assist device implantation in
implantable cardioverter-defibrillator patients
Fanny Boudghene, Stéphane Boulé, Céline Goéminne, Guillaume Schurtz,
Christelle Marquié, Claude Kouakam, Laurence Guédon, Salem Kacet,
André Vincentelli
CHRU Lille, Hôpital Cardiologique, Lille, France
Background: Little is known about clinical implications of the simulta-
neous use of left ventricular assist device (LVAD) and implantable cardio-
verter-defibrillator (ICD) in the same patient.
Methods: All patients who underwent LVAD (Heart Mate II) implantation
with concomitant ICD therapy at our institution between June 2007 and
August 2012 were included. We sought to investigate (1) electromagnetic
interferences between LVAD and ICD telemetry, (2) impact of LVAD place-
ment on right ventricular (RV) lead parameters, (3) ventricular arrhythmias
(VA) occurrence post LVAD implantation.
Results: The study population consisted of 23 patients (53±9 years, 73%
male, LVEF 19±9%). All brands of ICDs were implanted. The median dura-
tion of LVAD support was 182 [48-478] days. In three patients, ICD implan-
tation was performed after LVAD placement. Loss of ICD telemetry occurred
after LVAD implantation in 4 patients (St Jude Medical Atlas V-193, V-240,
V-243, and Sorin CRT 8750), requiring ICD replacement (n=2), metal
Figure – TeleMonitoring results 
Figure – Needle on the top of the first rib
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shielding use (n=1), and change in the programmer head position (n=1).
LVAD implantation was associated with a decrease in RV sensing threshold
(9.0 vs. 12.0 mV; p=0.04), a decrease in RV impedance (456 vs. 520 ohms;
p<0.01), and a trend towards an increase in RV pacing threshold (0.95 vs. 0.75
V; p=0.08), without clinical adverse consequences. Eleven patients (47.8%)
experienced ventricular arrhythmias under LVAD therapy, mostly well toler-
ated. Seven of these 11 patients experienced electrical storms, and 8 received
appropriate shocks. The single factor associated with the occurrence of VA in
LVAD recipients was a history of VA before LVAD implantation (p=0.003).
Conclusion: Electromagnetic interferences between LVAD and ICD
telemetry can require ICD replacement. LVAD placement is associated with
significant changes in RV lead parameters. VA occur in half of LVAD
patients, and their occurrence is strongly predicted by a history of VA before
LVAD implantation.
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Arrhythmic storm in patients with Heart Mate® II. Incidence, risk
factors and management
Jérôme Corré (1), Frédéric Sacher (1), François Picard (2), Arnaud Denis (1),
Adlane Zemmoura (1), Claire Loizeau (2), Nicolas Derval (1), Pierre
Bordachar (1), Joachim Calderon (3), Laurent Barandon (4), Michel Hais-
saguerre (1), Pierre Dos Santos (2), Pierre Jais (1)
(1) Hôpital Cardiologique du Haut-Lévêque, Rythmologie Pr Haissaguerre,
Pessac, France – (2) Hôpital Cardiologique du Haut-Lévêque, Pr Dos Santos,
Pessac, France – (3) Hôpital Cardiologique du Haut-Leveque, Anesthésie –
Réanimation cardiaque, Pr Ouattara, Pessac, France – (4) Hôpital Cardiolo-
gique du Haut-Lévêque, Chirurgie cardiaque, Pr Roques, Pessac, France
Background: Rhythmic complications seem common after left ventricular
(LV) assist device (LVAD), especially in the early phase of implantation
(<30 days), which can worsen the prognosis. We sought to identify the inci-
dence and risk factors of arrhythmic storm occuring after Heart Mate® 2
(HM2) implantation.
Methods:All patients with HM2 implanted in our institution have been
studied. Clinical data, occurrence of arrythmia, implantable cardioverter-defi-
brillator (ICD), ultrasound parameters as well as follow-up have been ana-
lyzed.
Results: From January 2008 to April 2013, 33 patients (30 men, 58 ±10 years,
LV Ejection Fraction 20 ±5%, ischaemic cardiomyopathy 82%, 70% bridge to
transplant) were included. Before implantation, 15 had ICD (12 for primary
prevention) and 11 had a history of sustained ventricular tachycardia (VT).
The overall mortality rate was 48% with a mean follow-up of 11 ±11 months.
Post-LVAD arrhythmic storm (10 patients, including 9 in the first 30 days)
were more frequent in patients with prior VT (70% vs 17%, p<0.01), prior
ICD (80% vs 30%, p=0.01), larger LV end diastolic diameter (77±9 vs 67±6
mm, p=0.02) and non ischaemic cardiomyopathy (40 vs 8,4%, p=0,053).
Arrhythmic storm occuring just prior implantation (8 patients) was not associ-
ated with arrhythmic storm recurrence after. Betablocker initiation post-
LVAD was carried out within the first month for only 4 patients. Endocardial
VT ablation was performed in 6. The substrate was not related to HM2 can-
nula. Atrial fibrillation was present in 18 (54%) during the early phase post
implantation.
Conclusion: Arrhythmic storm are frequent (33,3%) after Heart Mate®
2 implantation, often occurring within one month in patients with prior VT
episode (table above).
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Contributions of remote monitoring to the follow-up of 717 ICD/CRT-
D in a single center: a very low rate of inappropriate shocks
Pascal Defaye, Natacha Pellet, Peggy Jacon, Alix Martin, Radu Moisei
CHU Grenoble, Unité de Rythmologie, Grenoble, France
Remote monitoring (RM) is now accepted as a safe alternative to standard
follow-up (sFU).
Methods: We analysed the long term arrhythmic and device-related out-
comes of 717 ICD/CRT-D. Patients were equipped with Boston Scientific
Latitude (44%), Medtronic Carelink (42%), St Jude Medical Merlin (11%) or
Biotronik Home Monitoring (3%) systems. FU started after hospital
discharge. Automatic FU with RM was performed every 3 months, with at
least one sFU /year. In emergency cases patients were invited for in-hospital
visits.ICDs were programmed with 2 zones (VT >180 bpm / VF>220 bpm).
All RM alerts and related EGMs as well as the reasons and therapies were
reviewed by two physicians.
Results: We enrolled 717 patients (82% male,66±10 y). 55% had ischemic
cardiopathy, 66% were primary prevention. CRT-D (48%) and dual chamber
(43%) were mainly represented, single chamber 9%. During a RM FU period
of 22±11 months, we noted 13±9 automatic RM FU and 2±1 sFU visits/
patient. 65 deaths occurred. 45 patients had major alerts (13 for ICD lead dys-
function, 18 for ERI reached, 7 for electrical storm, 3 therapies off). Concerning
non major alerts, 80 CRT-D had loss of biventricular pacing (<85% of
Abstract 168 – Table. Characteristics between CASES (post implantation arrhythmic storm and WITNESSES (no arrhythmic storm)
Arrhythmic storm n=10 Witnesses n=23 p
Age (years) 59.6±10.2 57.0±10.8 0.53
Weight (kgs) 79.0±15.2 70.5±10.8 0.11
Body surface area (m2) 1.95±0.20 1.82±0.16 0.06
LVEF (%) 18.4±3.5 20.2±5.8 0.36
LVTDD before implantation (mm) 77.6±9.6 67.4±6.5 0.02
LVTDD after implantation (mm) 52.3±11.6 52.7±11.5 0.95
Turbine speed in first week (rpm) 9014±313 8952±391 0.53
ICD (n; %) 8 (80) 7 (30.4) 0.01
Prior sustained VT >1 month before HM II implantation (n; %) 7 (70) 4 (17) 0.006
Prior arrhythmic storm > 1 month before HM II implantation (n; %) 1 (10) 0 (0) 0.30
Sustained VT <1 month before HM II implantation (n; %) 5 (50) 8 (33.3) 0.33
Arrhythmic storm <1 month before HM II implantation (n; %) 2 (20) 6 (26,1) 0.78
Non ischaemic heart disease (n; %) 40 (40) 2 (8.7) 0.053
Acute cardiac dysfunction (n; %) 4 (40) 12 (52.2) 0.39
Bridge to transplantation (n; %) 7 (70) 16 (69.6) 0.66
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pacing). Within the 226 pts with diagnosed AF by RM, 41 patients had early
detection of unknown AF. 23,2% were managed with a rhythm control
strategy (cardioversions: 11,6%, AA drugs: 8,7%, PAF ablation: 2.9%) and
13% (all with CRT-D) had a rate control strategy (AVN ablation: 4,3% and
beta blocker:8,7%).173 appropriate (app) ICD shocks (ICDs) occurred in
56 pts (7,8%). 53 inappropriate (inapp) ICDs occurred in 22 pts (3,1%) and were
mostly due to AF (64%). 112 pts had 2077 app ATP (15.6% of the patients,
70% successful). 7 pts with high LV impedance had LV lead dislodgement and
underwent early intervention. Only 5,1% switched from RM FU to sFU.
Conclusion: In a large single center study, RM has demonstrated to be an
effective method of FU for ICD/CRT-D. Early diagnoses of AF or lead failure
allow rapid management of patients and are associated with a very low rate of
inapp shocks.
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Permanent cardiac pacing: first Congolese experiment
Méo Stéphane Ikama (1), Jospin Makani (1), Solange Mongo Ngamani (1),
Xavier Jouven (2), Gisèle Kimbally-Kaky (1), Jean Louis Nkoua (1)
(1) CHU Brazzaville, Cardiologie, Brazzaville, Congo – (2) Hôpital Euro-
péen Georges Pompidou (HEGP), Cardiologie, Paris, France
Purpose: To present profile of the first patients implanted of pacemaker in
Congo.
Patients and methods: A descriptive longitudinal study was conducted in
the Department of Cardiology and the operating theater of the University Hos-
pital of Brazzaville, from January to September 2012. It focused on eight
patients who underwent pacemaker implantation during a french pacing mis-
sion. The effect of pacemaker on symptoms and quality of life of patients was
assessed according to the CDC-HRQOL4.
Results: Mean age of patients was 70.4±6 years (range: 63-81 years).
There were four men and four women. Five patients were living in Brazzaville
and three came from other departments. Functional signs consisted in: dyspnea
(7 cases), syncope (3 cases), syncopal equivalents (2 cases). One patient was
asymptomatic. The average heart rate was 37.4 beats per minute (range; 27
and 49 beats). Blood pressure was normal in three patients; high in the others
of whom a woman with hypertension treated. Electrocardiogram showed: a
complete atrioventricular block (6 cases), an atrioventricular block of high
degree 2/1 (2 cases). Cephalic venous access was used in six patients and sub-
clavian in two others. All patients were implanted and stimulated in single
chamber ventricular (VVIR). Pacing thresholds were between 0.3 and
0.7 volts, without significant increase during follow-up. The percentage of
stimulation varied between 62 and 100%. At the ninth month ventricular spon-
taneous activities were detected in six patients and not detected in one patient.
The impedance probes were located between 336 and 707 ohms. All patients
notified improvement of symptoms and quality of life during the first month
of implantation. No complication has been observed.
Conclusion: This preliminary study showed the benefit of pacemaker
implantation on symptoms and quality of life of patients. So this activity
should been carried on.
Key words: Atrioventricular block, pacemaker, quality of life, Congo.
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Mortality in patients with heart failure treated with cardiac resyn-
chronisation therapy: A long term mono-center follow-up study
Serge Quenum, Akli Otmani, Houssam Bakkour, Paul Thirifays, Amel
Mathiron, Sarah Traulle, Mathieu Kubala, Jean Sylvain Hermida, Jean Luc
Rey
CHU Sud, Cardiologie et stimulation cardiaque, Amiens, France
Aim of study: To assess long term mortality of patients implanted with
biventricular pacing devices for  refractory heart failure(NYHA 3 or 4), left
bundle branche block, ejection fraction<35% and dilated cardiomyopathy.
Methods: This was a retrospective study performed in a single center.The
study population consisted of 100 consecutive patients implanted with  biven-
tricular pacing device in our center from 1999 to 2006. A visit was performed
in surviving patients and mortality data were obtained by hospital file review
or direct telephone contact.
Results: 82 patients (82%) were male. Mean age was 68±11 years, (39-83).
79 patients (79%) were in NYHA III.  46patients (46%) have ischemic étiology.
Mean follow up was 61± 43 months. During the study period, 76 (76%) patients
died. Survival is 83% at one year, 71% at two years, 48% at five years and 28%
at eight years. Among 76 patients who died, mode of death was worsening heart
failure in 20 patients (26%), sudden cardiac death in 15 patients (20%).37 patients
(49%) died from non cardiovascular etiology; mode of death was unknown in
4 patients (5%).
Conclusion: Mortality is high in patients implanted with biventricular
pacing device for refractory heart failure.Non cardiovascular mortality is the
more frequent etiology of death (49%)
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Outcomes in patients with Brugada syndrome treated with implanted
defibrillators.: a single center experience
Leila Abid (1), Ahmed Tounsi (2), Zied Frikha (1), Dorra Abid (2), Mou-
rad Hentati (3), Samir Kammoun (1)
(1) CHU Hédi Chaker, Cardiologie, Sfax, Tunisie – (2) FMS, University
Hédi Chaker Hospital, Cardiology, Sfax, Tunisie – (3) CHU Hédi Chaker,
Sfax, Tunisie
Introduction: Brugada syndrome is an arrhythmogenic disease character-
ized by an increased risk of sudden cardiac death (SCD) by ventricular fibril-
lation. At present, an implantable cardioverter-defibrillator (ICD) is the
recommended therapy in high-risk patients. This study reports the outcome of
a serie of patients implanted with an ICD for Brugada syndrome
Methods and results: We conducted a retrospective, single centre study of
11 patients (mean age: 40 ± 11 years) with BS, 4 of them underwent primary
prophylactic ICD implantation. All patients had baseline spontaneous
(11 patients) coved type I ECG pattern. All patients were judged to be at high
risk because of syncope (1 patient), a positive family history of sudden death
(1 patient) and/or ventricular arrhythmias at the electrophysiology study
(2 patients).
During 22±5.8 months of follow-up, no patient died and none of the 4
implanted patients had a sustained arrhythmia detected and/or ICD-related
adverse effects. The only complication was premature battery depletion that
required early ICD replacement in 2 patients. None of the asymptomatic and
no inducible patients experienced a cardiac event.
Conclusion: Risk stratification for patients with BS for primary prevention
remains challenging. The low risk of arrhythmic events that is exceeded by
ICD-related adverse effects should inform discussions with patients who do
not have a prior history of cardiac arrest
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Long-term follow-up after a tilt test in patients with syncope: results
of a French general hospital survey
Aymen Elhraiech, Fabien Monsel, Jacky Sergent, Walid Amara
CH Le Raincy-Montfermeil, Service Cardiologie, Montfermeil, France
Objectives: The objective of this study was to examine the long-term
follow-up of patients referred for a tilt test.
Methods: Between January 2009 and December 2012, all patients under-
going a head-up tilt test for recurrent syncope were studied. Follow up data
were obtained using telephone interviews and medical record reviews.
Results: A tilt test was realized in 77 patients (47,8±20 years, 53% female)
for an exploration of syncope. The tilt test elicited syncope or pre-syncope in
57 patients (74%). The positive response included vasovagal syncope in
53 patients and psychogenic syncope in 4 patients.
After the tilt test, patients with a positive response were reassured, coun-
seled about recognizing theirs symptoms and shown appropriate postured
maneuvers when pre-syncopal episodes occur.
Follow-up data were available for 48 patients with a positive tilt test and
19 patients with a negative test patients . After a mean follow-up of 32±11 months
(range 6 to 54 months), 10% of patients (7/67) had at least one recurrence of
syncope. Of note, the incidence of recurrence was the same regardless of whether
the patients had a positive (n=5/48; 10%) or a negative head-up tilt test response
(n=2/19; 10%).
Conclusion: Recurrence rate of syncope after a tilt test is low. However
our study suggests no correlation between tilt test results and the likelihood of
recurring syncope.
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Ultrasound-guided venous puncture in fully-anticoagulated patients
undergoing electrophysiological procedures is a safe and short
learning curve technique
Abdelkarim Errahmouni, Sok-Sithikun Bun, Decebal Gabriel Latcu, Emna
Allouche, Latifa Alkhouri, Nadir Saoudi
Centre Hospitalier Princesse Grace, Cardiologie, Monaco, Monaco
Background: Vascular complications remain a significant issue during
electrophysiological (EP)  procedures, especially when full anticoagulation
is needed as for atrial fibrillation (AF) or atrial flutter (AFl) catheter abla-
tion. Femoral artery palpation during a “blind” femoral vein puncture
often implies a collapse of the latter in patients (pts) in a fasting state,
while ultrasounds allow direct vizualisation. We investigated the effect of
ultrasound-guided venous puncture (UGVP), on the incidence of in-hos-
pital vascular complications defined as major (requiring blood transfusion
or surgery) or minor (groin hematoma without hospital stay lenghthening)
in fully-anticoagulated pts.
Methods: All pts eligible for EP procedures under anticoagulation (either
vitamine K antagonist VKA or dabigatran) were prospectively included. For
AF ablation, all pts were on VKA 4 weeks before the procedure with a target
international normalized ratio (INR) > 2, and continued VKA until the proce-
dure. Intravenous heparin boluses were given during AF procedures aiming an
activated clotting time > 300 s.  None of the 3 operators were trained in
UGVP technique before the beginning of the study.
Results: Fifty pts (67±12 y ; VKA n=45 , dabigatran n=5) underwent AF
(n=32), AFl (n=13), and other (n=5) ablation procedures. Mean INR in VKA
pts the day of the procedure was 2,49±0,54. UGVP was successfully achieved
in all pts. Mean time for 3.7±0.7 sheaths per pt insertion (1x6F and 2x8.5F
introducers), was 382 ± 145 sec. There was one minor vascular complication
(groin hematoma) out of 50 patients (2%) without major complication. UGVP
is a short learning curve technique (Figure above). 
Conclusion: UGVP is associated with a very low incidence of minor vas-
cular complications. This is a safe and non time-consuming  technique with a
short learning curve. 
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Defibrillators patients perception of daily life activities and medical
follow-up: a French survey 
Walid Amara (1), Saida Cheggour (2), Aymen Elhraiech (1), Hasna Salih
(1), Jerome Taieb (3), Pascal Sagnol (4), Nacera Rabah (5), Gael Glerici
(6), Sebastien Buffler (7), Fahmi Ghanem (8), Antoine Dompinier (9),
Paul Bru (10)
(1) CH Le Raincy-Montfermeil, Service Cardiologie, Montfermeil, France –
(2) CH Avignon, Avignon, France – (3) CH Aix, Aix En Provence, France –
(4) CH Chalon, Chalon Sur Saône, France – (5) CH Evreux, Evreux,
France – (6) CH St Pierre – La Réunion, St Pierre, France – (7) CH
Haguenau, Haguenau, France – (8) CH Châteauroux, Châteauroux,
France – (9) CH Annecy, Annecy, France – (10) CH La Rochelle, La
Rochelle, France
Introduction: The aim of our study was to assess patients' knowledge
about defibrillators after the implantation.
Material and methods: We performed a multicenter survey in 10 French
centers from January 2012 to december 2012. In each center, patients received
usual informations about defibrillator’s implantation, functioning, and about
their habits after the implantation. They signed a consent for implantation.
One to 10 days after implantation, all patients received a questionnaire. The
questionnaire evaluated patients' perceptions of information and consent, risks
of implantation; follow up, and about performing various routine activities.
We also evaluated the patients’ anxiety using the Beck Anxiety Inventory
Score and the health status of patients considered by themselves by a numer-
ical scale (between 0 and 100) .
Results: We included 119 patients. The mean age was 66.5+11.8 years
34- 82 yrs) and 87% were men. The intervention was a primary implanta-
tion in 79% of patients. We noted that 89% on the patients remember that
they have signed a consent and only 72% of patients remember that they
received counseling in the peri-operative period. A considerable propor-
tion of patients considered many routine activities unsafe including driving
automobiles (40%), passing through metal detectors (33%), sleeping on
the side of the defibrillator (48%). Also, 33% of patients think they can
use induction hobs and 72% think they can use mobile phone without any
precautions. Regarding medical imaging, 47%; 23% and 29% of patients
considered unsafe making scanners, radiography and echography respec-
tively; and 32% ignored if they can have MRI. Finally, regarding the med-
ical follow up, 18% of patients think they are exempt from monitoring by
a cardiologist.  
Despite an altered perceived health status (the mean of numerical scale was
33.7), the perceived anxiety was low (the mean of Beck anxiety inventory
score was 28.5). 
Conclusion: The results of our study highlight on patients’ misperceptions
on defibrillator functioning and the need in improving practices to better
inform patients. Thus, the quality of life of implanted patients may be
improved.
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Pacemakers’ patients perception of daily life activities and medical
follow-up: Final results of the CNCH survey 
Walid Amara (1), Saida Cheggour (2), Aymen Elhraiech (1), Hasna Salih (1),
Jerome Taieb (3), Pascal Sagnol (4), Nacera Rabah (5), Gael Glerici (6),
Sebastien Buffler (7), Fahmi Ghanem (8), Antoine Dompinier (9), Bernard
Lahitton (10), Karim Gacem (11), Aimé Bonny (12), Paul Bru (13)
(1) CH Le Raincy-Montfermeil, Service Cardiologie, Montfermeil, France –
(2) CH Avignon, Avignon, France – (3) CH Aix, Aix En Provence, France –
(4) CH Chalon, Chalon Sur Saône, France – (5) CH Evreux, Evreux,
France – (6) CH St Pierre – La Réunion, St Pierre, France – (7) CH
Haguenau, Haguenau, France – (8) CH Châteauroux, Châteauroux,
France – (9) CH Annecy, Annecy, France – (10) CH Dax, Dax, France –
(11) CH Cholet, Cholet, France – (12) Hôpital Saint Camille, Bry Sur
Marne, France – (13) CH La Rochelle, La Rochelle, France
Introduction: The aim of our study was to assess patients' knowledge
about pacemakers after the implantation.
Material and methods: We performed a multicenter survey in 13 French cen-
ters from January 2011 to July 2012. In each center, patients received usual infor-
mations about pacemaker implantation, functioning, and about their habits after
the implantation. They signed a consent for implantation. One to 10 days after
implantation, all patients received a questionnaire. The questionnaire evaluates
patients' perceptions of information and consent, risks of implantation, follow up,
and about performing various routine activities (daily life activities, use of elec-
trical devices, ability to undergo medical imaging tests).
Results: We included 258 patients. The mean age was 75.6 + 10.6 years 34-
102 yrs) and 61% were men. The intervention was a primary implantation in 89%
of patients. We noted that 78% on the patients remember that they have signed a
consent and 73% of patients remember that they received counselling in the peri-
operative period. A considerable proportion of patients considered many routine
activities unsafe including driving automobiles (30%), swimming (39%), passing
through metal detectors (47%), sleeping on the side of the pacemaker (42%). Also,
28% of patients think they can use induction hobs and 18% think they can use arc
welding equipment. Regarding medical imaging, 45%; 29% and 33% of patients
considered unsafe making scanners, radiography and echography respectively; and
41% ignored if they can have MRI. Finally, regarding the medical follow up, 11%
of patients think they don’t need heart medications and 17% of patients think they
are exempt from monitoring by a cardiologist.
Conclusion: The results of our study highlight on patients’ misperceptions
on pacemaker functioning and the need in improving practices to better inform
patients. Thus, the quality of life of implanted patients may be improved.
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New Arctic Front Advance® cryoballoon improves efficacy of
paroxysmal atrial fibrillation ablation
Nathanael Auquier, Frédéric Anselme, Arnaud Savouré, Bénédicte Godin,
Kévine Gardey, Héléne Eltchaninoff
CHU ROUEN, Cardiologie, Rouen, France
Background: Ablation of paroxysmal atrial fibrillation (pAF) using a
cryoballoon catheter is currently expanding. PAF ablation success rate with
the Arctic Front® cryoballoon (AFB) has been found to be similar to what is
observed with radiofrequency catheter. Recently, the new Arctic Front
Advance® cryoballoon (AFAB) has become available. We aimed to assess its
efficacy compared to the previous version of cryoballoon.
Methods and results: Pulmonary vein isolation (PVI) was performed in
74 consecutive patients suffering from pAF. The first 47 were treated with the
AFB, whereas the AFAB was used in the last 27. In all patients PVI was con-
firmed at the end of the procedure. Mid-term success was defined as lack of
symptoms suggesting AF, and absence of documented AF on ECG or 24 h
Holter monitoring at 4 months follow up.
The procedure time, fluoroscopy time and dose were significantly reduced
when using the AFAB as compared to the AFB (92 min vs 130, p<0.01;
17 min vs 19 min, p=0.010; 21 Gy/cm² vs 27, p=0.045). The major complica-
tion rates were similar in both groups (p=0.342). The antiarrhythmic and anti-
coagulant medications were stopped much earlier after the procedure in the
AFAB compared to the AFB group (89% vs 55%, p=0.034 and 52% vs 40%,
p<0.01, respectively). The mid-term success rate was significantly higher in
the AFAB as compared to the AFB group (81% vs 49%, p<0.01).
Conclusion: The use of the new AFAB seems associated with a better outcome
as compared to the AFB, without increasing the procedural complication rate.
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Prospective evaluation of right bundle branch block pattern during
right ventricular apical pacing. Looking for a mean to lowering the
harmful effect of standard cardiac pacing
Philippe Maury (1), Tin Tran Xuan (2), Pierre Mondoly (2), Alexandre
Duparc (2), Anne Rollin (2), Christelle Cardin (2), Emilie Thomson (2),
Amin Bennadji (2), Marc Delay (2)
(1) CHU Rangueil, Cardiologie, Toulouse, France – (2) CHU Rangueil,
Toulouse, France
Background: right bundle branch block pattern (RBBB) may be casually
seen during apical right ventricular pacing, whose prevalence and mechanisms
are poorly known. Knowing how to produce such ECG pattern would lead to
less dyssynchrony during standard cardiac pacing.
Methods: 60 pts were prospectively implanted with single or dual chamber
pacemaker (PM) for anti-bradycardial usual indications with a ventricular lead posi-
tioned at the right ventricular apex in each case (30 with the PM on the right site
and 30 on the left site). RBBB during VVI or DDD pacing with short AV delay was
defined by a positive or isoelectrical QRS complexe in V1 and/or V2 leads. Left
bundle branch block (LBBB) was defined by a negative QRS in V1 and V2.
Results: mean age was 79 ±10 yo, 35/60 (58%) were men. There was no heart
disease in 56%. AFib was present in 13%. In patients with persistant spontaneous
AV conduction (42 pts, 70%) QRS morphology before implantation displayed
RBBB in 20%, LBBB in 23% and narrow QRS in 57%. Indication for pacing was
AV conduction disturbances in 80%. 11/30 implanted pts on the right side (36%)
had RBBB during pacing vs 4/30 (13%) implanted pts on the left side (p=0.03)
(25% RBBB for the 60 pts). QRS duration or axis were similar either the pts were
implanted on the right or left side or pacing was unipolar or bipolar. None of the
usual clinical or ECG parameters (age, ejection fraction, heart disease, QRS mor-
phology or axis, spontaneous AV conduction or PM indication) were correlated to
the RBBB/LBBB pattern during pacing.
Conclusion: RBBB during ventricular pacing may be observed in 25% of
pts implanted at the right ventricular ape, more often if the PM is implanted
on the right side. Pathophysiological explanation deserve further studies for
possibly leading to less dyssynchrony during standard cardiac pacing.
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Safety of transvenous pulmonary vein isolation for the treatment of
atrial fibrillation: a prospective randomized study comparing an open
irrigated and an internal irrigated tip radiofrequency cathete
Laurence Jesel (1), Claudia Herrera Siklody (2), Dietmar Trenk (2),
Christian Stratz (2), Christian M. Valina (2), Reinhold Weber (2), Jan
Minners (2), Dietrisch Kalusche (2), Florence Toti (3), Olivier Morel (4),
Thomas Arentz (2)
(1) Hopitaux Universitaires de Strasbourg, Strasbourg, France – (2) Herz-
zentrum, Bad Krozingen, Allemagne – (3) INSERM 770 et Université de
Strasbourg, Strasbourg, France – (4) NHC, Pôle d'activité médico-chirur-
gicale cardiovasculaire, Strasbourg, France
Background: Irrigated tip radiofrequency (RF) ablation catheters are widely
used for transvenous pulmonary vein isolation (PVI) in the treatment of atrial
fibrillation (AF). Internal irrigated tip (IIT) catheters have the advantage of lower
risk of fluid volume overload, especially in patients with heart failure. However, it
has been suggested that they might have a higher thromboembolic risk. 
We aimed to compare the safety of both systems by measuring sensitive
laboratory markers of platelet activation, cell damage, and inflammation after
PVI using either an open irrigated tip (OIT) or an IIT- RF catheter.
Methods: Sixty patients with symptomatic, drug-resistant AF referred for PVI
(57±4 years old, 44 males, 32 with paroxysmal and 28 with persistent AF) were
© Elsevier Masson SAS. All rights reserved.
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randomly assigned to undergo a PVI using either an OIT-catheter (Thermocool®,
Biosense) or an IIT-catheter (Chilli II®, Boston Scientific) for ablation. Systemic
markers of cell damage (procoagulant microparticles [MP - total annexin-V cap-
tured MP and MP of various cellular origin]), troponin T, CK and CK-MB),
platelet activation (ADP-induced light transmittance aggregometry [LTA] and
expression of platelet surface proteins P-selectin [pSEL] and activated GPIIb/IIIa
[PAC-1]) as well as inflammatory response (high sensitive C-reactive protein – hs-
CRP) were monitored before ablation and 6, 24 and 48 hours after the procedure.
Results: PVI induced a significant increase in hs-TnT, CPK, microparti-
cles, markers of platelet activation and inflammation. Maximum values were
observed at 24 hours for tissue damage markers and platelet activation. Hs-
CRP and leukocyte-derived microparticles were still increasing at 48h. There
was no significant difference in these parameters between patients ablated
with OIT or IIT. No significant difference in procedure time, fluoroscopic
time, complication or success rate was observed.
Conclusions: PVI using either OIT or IIT resulted in a comparable increase in
markers of cell damage, platelet function and inflammatory response. These data
suggest a similar safety and efficacy profile in PVI with both catheters. Therefore,
IIT should be reconsidered in heart failure AF patients.
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Feasibility and safety of temporary subcutaneous venous figure of eight
closure to achieve hemostasis after atrial fibrillation cryoballoon ablation
Sarah Traullé, Maciej Kubala, Paul Thiriphays, Jean-Sylvain Hermida
CHU Sud, Centre d'activité de rythmologie, Amiens, France
Introduction: Prolonged compression for hemostasis can be time con-
suming, uncomfortable and associated with bleeding complication. The aim of
our prospective study was to evaluate the feasibility and safety of venous figure
of eight closure to achieve hemostasis after atrial fibrillation (AF) ablation. 
Methods: Consecutive patients who underwent AF or left atrial tachycardia
catheter ablation were enrolled in the study from February 2012 to November 2012.
At the end of the procedure, a silk suture was passed on the caudal side of the sheath
deeply into the subcutaneous tissue. Patients were kept in bed for 12 hours before
ambulation. Anticoagulation was performed according to guidelines.
Results: Sixty-six patients which mean age was 58±10 years old were
included. 67% were male, 45% had hypertension. 82% suffered from parox-
ysmal AF and were treated by cryotherapy which leads to an important use of
12-F sheath. Femoral punctures were performed 2.5±1 [2-7] time. Concerning
anticoagulation, mean INR was 1.6±0.4, ACT at the end of procedure was
336±66 s and heparinemy controlled after 6 hours was 0.84±0.40 UI anti Xa/ml.
Figure of eight suture closure technique was used for all patients but after
observation of the site for few minutes, mechanical external compression was
applied for 10 patients (15%). In 3 of 66 patients a hematoma was diagnosed
(4.5%) with hemoglobin that dropped from 13.8±2.1 to 12.2±2.1. Two
patients acquired an arteriovenous fistula that closed spontaneously. It was
considered as a complication of the femoral puncture itself and not a compli-
cation of the suture closure technique. No risk factor of hematoma (level of
anticoagulation, hypertention, gender, etc) could be identified.
Conclusion: Figure of eight suture closure technique can be used as an
alternative to usual compression methods to prevent bleeding during high-
intensity anticoagulation, the use of large-caliber venous sheaths and multiple
femoral venous accesses.
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Correlation between resting heart rate and apnea-hypopnea index
during obstructive sleep apnea
Afef Ben Halima (1), Houcine Chammam (1), Sonia Maalej (2), Zied Bel
Hadj (1), Sonia Marrakchi (1), Samira Chine (1), Faouzi Addad (1), Ikram
Kammoun (1), Salem Kachboura (1)
(1) Hôpital Abderrahmen Mami, Service de cardiologie, Ariana, Tunisie –
(2) Hôpital Abderrahmen Mami, Service de pneumologie, Ariana, Tunisie
Introduction: The resting heart rate depends on the dynamic balance
between the sympathetic and parasympathetic nervous system.
The obstructive sleep apnea is a disease that interferes strongly with the
autonomic nervous system and disrupts this balance.
Purpose: The purpose of our work is to study the impact of the severity of
obstructive sleep apnea (assessed by the apnea-hypopnea index (AHI)) on the
resting heart rate.
Materials and Methods: This is a retrospective study of 30 patients. 
All patients with obstructive sleep apnea and who were in sinus rhythm
were included.  Patients who were taking a treatment with a negative chro-
notropic effect were excluded.
Heart rate was calculated on a surface 12 lead ECG performed at rest and
before the treatment of the obstructive sleep apnea. .
The AHI was determined by polygraphy.
Results: The average age of patients was 57.4±10.5 years, the sex ratio
was 0.23. The mean BMI was 37.87±6.98 kg / m².
Sixteen patients had severe obstructive sleep apnea (AHI> 30), seven had
moderate obstructive sleep apnea (AHI between 15 and 30), and six mild
obstructive sleep apnea (AHI between 5 and 15).
Twenty-two were hypertensive under treatment other than beta-blockers
and two patients had a well-balanced treatment of hypothyroidism.
There was a positive correlation between heart rate and apnea-hypopnea
index was (r=0.49, p<0.001).
Conclusion: our study shows that there is a relation between the severity
of untreated obstructive sleep apnea and resting heart rate. The higher is the
heart rate the more severe is the obstructive sleep apnea. These results suggest
the higher sympathic tone in severe obstructive sleep apnea predisposing to a
higher incidence of cardio-vascular complications
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Effect of age on the presentation and the follow-up of patients with
supraventricular tachycardia 
Maxime Benichou, Béatrice Brembilla-Perrot
CHU Brabois, Cardiologie, Vandoeuvre Les Nancy, France
The purpose of the study was to look for the influence of age on indica-
tions, clinical data and long-term results of radiofrequency ablation of parox-
ysmal supraventricular tachycardia (SVT). 
Methods: 1518 patients, 610 males, 908 females, mean age 49±19 years
were referred for SVT. Clinical history, SVT-related complications, data of
echocardiography and methods of treatment were collected. Patients were fol-
lowed from 3 months up to 10 years.
Results: 1268 patients were <70 years (group I) and 250 aged from 70
to 97 years (group II), 178 from 70 to 79 years (group IIA) and 72 from
80 to 97 years (group IIB). Heart disease was more frequent in group II
(26%) (group IIA:30%, group IIB:18%) than in group I (9%) (p<0.0001).
Atrial fibrillation (AF) history was as frequent in group I (2%) and II (4%)
(group IIA:3%;group IIB:4%) (NS). SVT-related adverse events (coronary
ischemia, heart failure, syncope, ventricular tachyarrhythmias) were less
frequent in group I (12.5%) than in group II (28%(p<0.0001) (group
IIA:27%,group IIB:32%). During follow-up (3±3 years), SVT ablation was
indicated less frequently in group I (62.5%) than in group II (73%)
(p<0.002) (group IIA:73%, group IIB:72%). Failure of ablation was rarer
in group I (11%) than in group II (19%) (p<0.0009) (group IIA: 20%,
group IIB:16%). SVT ablation-related complications were less frequent in
group I (3.5%) than in group IIIB:7%) ((p<0.011). Late occurrence of AF
was as frequent in group I (5%) and II (7%), but AF was more frequent in
group IIA (8%) than in group I (p<0.04). Cardiac deaths were less fre-
quent in group I (2%) than in group II (5%) (p<0.001) (group IIA:5%,
group IIB:7%). 
Conclusions: Old patients had frequent SVT-related adverse presentation.
Therefore SVT ablations were more frequently indicated in old patients.
Among patients aged ≥70 years, there were no difference between patients
aged less than 80 years and those aged ≥80 years. Risk of AF development
and cardiac death remained higher in old patients.
© Elsevier Masson SAS. All rights reserved.
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Does the mechanism of paroxysmal supraventricular tachycardia
change the frequency of associated atrial fibrillation?
Béatrice Brembilla-Perrot, Jean Marc Sellal, Jérôme Schwartz, Arnaud
Olivier, H Khachab, Christian De Chillou, Mariud Andronache, Diana
Tint, Claire Lalevee, Pierre Yves Zinzius, Daniel Beurrier, Philippe
Admant
CHU Brabois, Cardiologie, Vandoeuvre Les Nancy, France 
The purpose of study was to evaluate the role of the mechanism of parox-
ysmal of paroxysmal supraventricular tachycardia (SVT) on the incidence of
spontaneous atrial fibrillation (AF). 
Methods: 47 patients, mean age 57±15 years with SVT and normal ECG
in sinus rhythm (group I) were referred for AF. They were issued from a
group of 1481 patients with SVT and normal ECG (49±19 years). 31 patients
with SVT and preexcitation syndrome in sinus rhythm were referred for AF
(group II) (44±15 years). They were issued from a group of 378 patients with
preexcitation syndrome and SVT (34±17 years). Electrophysiological study
was performed in control state and after isoproterenol. Patients were followed
from 3 months to 20 years (mean 3±2 years).
Results: In group I, SVT was related to typical atrioventricular (AV) nodal
tachycardia (AVNRT) (n=38) (81%), to atypical AVNRT (n=3) (6%) and to
AV re-entrant tachycardia (AVRT) (n=6) (12.5%) using concealed accessory
pathway (AP): the frequency of AF was similar whatever the mechanism of
SVT (4, 2, 2%), but the frequency of AF was higher in group II (8%) than in
typical AVNRT (p<0.0007), atypical AVNRT (p<0.005) and concealed AP
(p<0003). SVT ablation performed in 41 patients of group I (87%) suppressed
the risk of subsequent AF in 16 of 33 patients with typical AVNRT (48%), 4
of 6 patients with AVRT (67%), and 1 of 2 patients with atypical AVNRT
(50%) (NS). In patients with no previous AF, AF occurred in 35 of 902
patients in whom ablation was performed (4%) (p<0.0001); 4 of 23 group II
patients treated by ablation had still AF (17%). AF occurred in 9 of
207 patients (4%) (p<0.01) of group II without AF treated by ablation.
Conclusions: In patients with a normal ECG and SVT, AF was rare (3%),
independent on the mechanism of SVT; the risk of AF after ablation was high
(51%). In patients with overt preexcitation syndrome and SVT, AF was more
frequent (8%) and the risk of AF after ablation was lower (17%) (p< 0.0001),
but higher than in patients without previous AF (4%).
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The safety of cardiac resynchronization therapy pacemaker implanta-
tion in octagenarians: a monocentric experience
Michael Peyrol, Pascal Sbragia, Benjamin Obadia, Marc Laine, Chloé
Villacampa, Johan Pinto, Sébastien Armero, Laurent Bonello, Franck
Thuny, Franck Paganelli
CHU Nord, Service de Cardiologie, Marseille, France
Background: Octogenarians, often presenting with associated severe co
morbidities, are underrepresented in clinical trials on cardiac resynchroniza-
tion therapy (CRT). Whether CRT is a realistic option for heart failure (HF)
treatment in this increasing population is unknown. We report our experience
in CRT pacemaker implantation in patients over 80 years.
Methods and Results: Forty consecutive patients, 19 men (47.5%), with a
mean age of 84.8±3.1 years (range 80 to 90 years) were included in present
study. Patients with previous cardiac pacemaker placement were excluded
from this analysis. Thirty patients (75%) were in NYHA class III and 10 in
ambulatory NYHA class IV. Prior myocardial infarction was the cause of left
ventricular systolic dysfunction in 23 patients (57.5%) whereas dilated cardio-
myopathy was diagnosed in the remaining 17 patients (42.5%). Mean LVEF
was 27.0±7% (range 15% to 35%) and mean QRS duration was 152±18 ms
(range 120 ms to 200 ms) with left bundle branch block pattern in 30 patients
(75%). All 40 patients indicated for CRT underwent successful CRT pace-
maker implantation. Mean procedural duration and radiation exposure were
70.5±28.5 min (range 42 min to 165 min) and 15.5±12.4 min (range 4 to
32 min) respectively. Post-implantation follow-up was 1 month. Complica-
tions were observed in 3 patients (7.5%). One patient died from refractory HF
precipitated by bacteriemia at day 3. No evidence of material infection was
found. Then, left ventricular lead dislodgment requiring revision procedure
was observed in 1 patient. Finally, insulator fracture of atrial lead requiring
device programming was noted in one patient.
Conclusion: CRT implantation is feasible in octogenarians. The rate of
procedure-related complications is comparable to those reported during larger
randomized clinical trials.
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Electrocardiographic patterns in a young and healthy Algerian
population
Sid-Ali Bouallouche (1), Naima Hammoudi (2), Aymen Elhraiech (1),
Aylin Iusuf (1), Rachid Bougherbal (2), Walid Amara (1)
(1) CH Le Raincy-Montfermeil, Service Cardiologie, Montfermeil, France –
(2) EHS Maouche, Service Cardiologie, Alger, Algérie
Objective: Electrocardiographic characteristics and abnormalities in the
Maghrebian population haven't yet been well described. The aim of this study
was to evaluate the prevalence of electrocardiographic abnormalities in this
population by screening a sample group of apparently healthy young Algerian
persons.
Methods: A prospective observational study was performed using a
sample group of 441 healthy male and female subjects (mean age 25; ranges
from 18 to 36). All the subjects underwent a cardiac evaluation which com-
prised a medical history, a physical examination and a 12-lead electrocardio-
gram (ECG) at rest. The ECGs were analysed by three independent
cardiologists.
Results: The participants were asymptomatic, with no history of sudden
cardiac death. Their physical exam was normal. The mean HR was 75 bpm,
the mean PQ, QRS and QTc  duration was 150ms , 78ms and 402ms, respec-
tively. The mean QRS axis was 54°. 24 subjects (5.4%) were found with Left
ventricular hypertrophy (Sokolow index >35mm). First degree AV block was
present in 15 patient (3.4%). 3 participants were found with a complete RBBB
(0.6%), and 1 subject had a complete LBBB (0.2%) . Curiously the cases of
incomplete LBBB (22; 5%) were 4 times more often than the incomplete
RBBB cases (5; 1%).  A QRS axis <-30° was found in 7 patients  and
1 patient had an axis >120°. There were no short QTc (< 320ms). 7 (1.6%)
cases of long QTc (>460 ms) were discovered.
Conclusion: In our study, 76 patients, meaning 17.2% of the participants
were found with an ECG abnormality but without presenting any symptoms
nor abnormalities at the clinical examination. These data suggest that guide-
lines for the ECGs analysis should be adjusted to the target population.
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Common atrial flutter ablation in real life. The French Electra survey
Jerome Taieb 
CH Aix en provence, Cardiologie, Aix En Provence, France
Aims: to analyze AFl ablation habits in France. 
Method: A survey was e-mailed to 140 french electrophysiologists. They
were interviewed on their routine own strategy. When appropriate, physicians
could answer «not standardized» or «other».
Results: 103 physicians answered. AFl ablation is performed after the first
episode by 95%. Cavotricuspid isthmus (CTI) block is checked by 77% An
8mm and 4 mm irrigated ablation catheter is used by 80% and 14% respec-
tively for a first procedure, 56% and 36% in case of redo. Patients are dis-
charged on the day of ablation by 5%, next day by 77% and 2 days later by
16%. In case of anticoagulation with Vitamin K antagonist, 92% do not inter-
rupt it.
Conclusion: Most French electrophysiologists ablate after the first episode
of AFl, validate CTI blocking. 8 mm catheter is preferred to irrigated tip cath-
eter especially for the first procedure.
© Elsevier Masson SAS. All rights reserved.
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Silent atrial fibrillation after ischemic stroke: interest of continuous
ECG monitoring
Vanessa Fernandez (1), Yannick Bejot (2), Marianne Zeller (3), Joelle
Hamblin (1), Maud Maza (1), Claude Touzery (1), Yves Cottin (1), Maurice
Giroud (2)
(1) CHU Bocage, Cardiologie, Dijon, France – (2) Faculté de Médecine,
Université de Bourgogne, Dijon Stroke Registry, Dijon, France –
(3) INSERM U866, LPPCM, Faculté de Médecine, Dijon, France
Background: Atrial fibrillation (AF) is a major etiological factor of of
ischemic strokes. Recent data suggested that subclinical, i.e. silent AF,
assessed at the acute phase of stroke by Continuous ECG Monitoring (CEM)
is frequent, and associated with a worse prognosis. The aim of our study was
to investigate the incidence and determinants of silent AF in patients with
acute ischemic stroke (IS).
Methods: All the consecutive patients admitted on the stroke unit of CHU
DIJON for IS or TIA were prospectively enrolled from March to December
2012. Patients with a history of AF or who experienced symptomatic AF
during their hospital stay were excluded. Silent AF was assessed by CEM for
24h after admission and defined as at least 1 episode > 30 sec without
p waves, and with irregular RR intervals. An echocardiography was performed
at 2±1 d to measure left ventricular ejection fraction (LVEF) and left auricular
(LA) dimensions.
Results: Among the 187 patients included, 19 (10%) developed silent AF.
Patients with silent AF were markedly older (76 vs. 66 years, p<0.002), with
lower creatinine levels (90 vs. 80 μmol/L, p=0.030) and were less often
smokers (5 vs. 41% p=0.058) than patients without silent AF. They also
showed a trend towards more frequent hypertension (79 vs. 58%, p=0.057)
and a recent history of infection (16 vs. 5%, p=0.082). There was no
difference for chronic treatments, NIHSS score on admission, maximal heart
rate (HR) or diabetes. By backward multivariate analysis, only age remained
an independent estimate of silent AF. For echocardiographic measurements,
patients with silent AF showed a trend towards a larger indexed LA volume
(37.4 vs. 30.8 ml/ m3), p=0.057) and LA diameter (23.2 vs. 20.8 mm/m²,
p=0.059); LVEF was similar for the two groups (59 vs. 59%, p=0.582). 
Conclusion: This study demonstrated that silent AF detected by CEM is
common and associated with older age. Further studies are needed to investi-
gate the interest of systematical screening for silent AF for secondary preven-
tion after ischemic stroke.
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Spectrum and prevalence of rare variants in 168 genes in 189 patients
affected with J Wave syndromes using next generation sequencing
Jean-Baptiste Gourraud (1), Vincent Portero (2), Stéphanie Bonnaud (2),
Stephanie Chatel (1), Xavier Daumy (2), Pierre Lindenbaum (2), Laeticia
Dubosc-Bidot (2), Raluca Teusan (2), Hervé Le Marec (2), Jean Jacques
Schott (2), Florence Kyndt (2), Vincent Probst (1), Richard Redon (2)
(1) CHU Nantes HGRL, L'Institut du Thorax, Nantes, France – (2) UMR
1087, IRT UN, L'institut du thorax, Nantes, France
Introduction: Several gene defects have been associated with J wave syn-
dromes. However, the genetic basis of Early Repolarization <syndrome (ERS)
and Brugada Syndrome (BrS) and the prevalence of mutations in genes
involved in cardiac electrophysiology remains largely unknown. The recent
development of NGS-based mutation screening gives us a unique opportunity
to estimate extensively the spectrum and prevalence of rare variants in genes
already involved in cardiac arrhythmias.
Methods: Ninety-five and ninety-four index patients respectively affected
with spontaneous type 1 or symptomatic BrS and with ERS were enrolled.
Diagnosis was established after a double blind review, only if morphological
cardiac abnormalities or other diseases were excluded. We designed a custom
kit (CARDIOPLEX) using HaloPlex™ Target Enrichment System (Agilent)
prior to HiSeq sequencing. This kit covers 168 genes including every gene
previously reported as involved in cardiac arrhythmias, conduction defect and
cardiomyopathy and every gene identified as a candidate, based on our recent
NGS-based investigations performed on familial cases.
Results: The mean age of the patients was respectively 46±14 and
36±16 years old for BrS and ERS. Twenty-seven (28%) and ninety-four
(100%) patients were respectively symptomatic. 
In Brs patients, the PR interval was 167±29 ms, QRS duration was
106±14 ms and QTc interval 415±34 ms. 
In ERS patients, the PR interval was 163±38 ms, QRS duration was
90±17 ms and QTc interval 398±34 ms. The ER was present in inferior leads
in 32 (38%), in lateral leads in 15 (18%) and in both lateral and inferior leads in
36 (43%) with a mean J point elevation amplitude of 1.98±1.08 mm.
The sequencing results are now under analysis, with more than 95% of tar-
geted sequence positions covered at least 10 times.
Conclusion: This NGS-based assay will enable to get a comprehensive
picture of the spectrum and prevalence of mutations altering J wave syndrome
susceptibility genes. Moreover, this study will allow deep characterization of
genotype-phenotype relationships, thus leading to a better comprehension of
BrS and ERS physiopathology.
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Efficiency of heparin infusion may take more than 20 minutes during
ablation of atrial fibrillation
Anne Rollin (1), Vincent Gabus (2), Denis Graf (2), J Schlaepfer (2),
M Fromer (2), P Maury (1), A Forclaz (2), P Pascale (2), E Pruvot (2)
(1) CHU Rangueil, Toulouse, France – (2) CHUV, Lausanne, Suisse
Background: Catheter ablation of atrial fibrillation (CA-AF) is associated
with peri-procedural ischemic stroke (IS) in 0.5% and with asymptomatic IS
in 10-30% of patients (pts). The two major IS risk factors during CA-AF are
electrical cardioversion and poor iv anticoagulation (activated coagulation
time, ACT <250 sec). The Aim of our study is to analyze the temporal kinetics
of iv Heparin as measured by ACT during CA-AF.
Methods: 93 consecutive pts (60±10 y) suffering from drug-refractory AF
underwent CA-AF two days after interruption of Warfarin. After transseptal
puncture, a bolus of 100 U/kg of Heparin (8’484±1’659 U) followed by
100 ml of saline were infused using a forearm venous access to reach an ACT
value ≥300sec. ACT values were measured before (T0), at 10 (T10) and 20
(T20) min following the infusion.
Results: The figure shows the temporal kinetics of ACT values for the
93 pts. A significant increase was noticed from a mean value of 99±27sec at
T0 to 355±98sec at T10 and to 377±92sec at T20 (p<0.003, T0 vs T10/T20
and T10 vs T20). Importantly, ACT values were <300sec in 25% (23/93) of
the pts at T10 and in 15% (14/95) at T20.
Conclusion: Heparin infusion displays unexpected slow anticoagulation
kinetics following forearm infusion in a significant proportion of CA-AF pro-
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Figure – Temporal kinetics of ACT values for the 93 pts
